Nanoscope Therapeutics Announces First Patient Dosed in STARLIGHT Phase 2 Clinical Trial of MCO-010 Optogenetic Gene Therapy for Stargardt Disease ...
https://www.google.com/url?rct=j&sa=t&url=https://www.biospace.com/article/releases/nanoscope-therapeutics-announces-first-patient-dosed-in-starlight-phase-2-clinical-trial-of-mco-010-optogenetic-gene-therapy-for-stargardt-disease/&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AOvVaw1mK0lxaNEEAZQ0G_KUcivH
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.